IP Library Granted Patent US 9,637,727
Granted Patent B2
US 9,637,727 · App. 14/513,057 · Granted May 2, 2017

Polypeptides having xylanase activity and polynucleotides encoding same

Inventor: Nikolaj Spodsberg (Bagsvaerd, DK)
Assignee: Novozymes, Inc.
C12N9/2482C12N9/248C12P19/02C12P19/14C12Y302/01008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,637,727
App. No.
14/513,057
Granted
May 2, 2017
Kind
B2
Abstract

The present invention relates to isolated polypeptides having xylanase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.

Claims (31)

1. A nucleic acid construct comprising a polynucleotide encoding a polypeptide having xylanase activity, wherein the polynucleotide is operably linked to one or more heterologous control sequences that direct the production of the polypeptide in an expression host and wherein the polypeptide having xylanase activity is selected from the group consisting of:

(a) a polypeptide having at least 85% sequence identity to the sequence of amino acids 18 to 364 of SEQ ID NO: 2; and

(b) a fragment of the sequence of amino acids 18 to 364 of SEQ ID NO: 2 that has xylanase activity.

2. The nucleic acid construct of claim 1 , wherein the polypeptide having xylanase activity has at least 85% sequence identity to the sequence of amino acids 18 to 364 of SEQ ID NO: 2.

3. The nucleic acid construct of claim 1 , wherein the polypeptide having xylanase activity has at least 90% sequence identity to the sequence of amino acids 18 to 364 of SEQ ID NO: 2.

4. The nucleic acid construct of claim 1 , wherein the polypeptide having xylanase activity has at least 95% sequence identity to the sequence of amino acids 18 to 364 of SEQ ID NO: 2.

5. The nucleic acid construct of claim 1 , wherein the polypeptide having xylanase activity has at least 97% sequence identity to the sequence of amino acids 18 to 364 of SEQ ID NO: 2.

6. The nucleic acid construct of claim 1 , wherein the polypeptide having xylanase activity comprises the sequence of SEQ ID NO: 2.

7. The nucleic acid construct of claim 1 , wherein the polypeptide having xylanase activity comprises the sequence of amino acids 18 to 364 of SEQ ID NO: 2.

8. The nucleic acid construct of claim 1 , wherein the polypeptide having xylanase activity is a fragment of SEQ ID NO: 2, wherein the fragment has xylanase activity.

9. The nucleic acid construct of claim 1 , wherein the polypeptide having xylanase activity is encoded by a polynucleotide that hybridizes under very high stringency conditions with the full-length complement of the sequence of nucleotides 52 to 1165 of SEQ ID NO: 1, wherein the very high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 micrograms/ml sheared and denatured salmon sperm DNA, and 50% formamide, and washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 70° C.

10. The nucleic acid construct of claim 1 , wherein the polypeptide is a variant of the sequence of amino acids 18 to 364 of SEQ ID NO: 2 comprising a substitution, deletion and/or insertion at one or more positions and wherein the variant has at least 95% sequence identity to the sequence of amino acids 18 to 364 of SEQ ID NO: 2.

11. An isolated recombinant host cell transformed with the nucleic acid construct of claim 1 .

12. A method of producing a polypeptide having xylanase activity, comprising:

(a) cultivating the recombinant host cell of claim 11 under conditions conducive for production of the polypeptide; and

(b) recovering the polypeptide.

13. An isolated recombinant host cell transformed with a nucleic acid construct comprising a polynucleotide operably linked to one or more control sequences that direct the production of a polypeptide in the recombinant host cell, wherein the polypeptide is selected from the group consisting of:

(a) a polypeptide having at least 85% sequence identity to the sequence of amino acids 18 to 364 of SEQ ID NO: 2; and

(b) a fragment of the sequence of amino acids 18 to 364 of SEQ ID NO: 2 that has xylanase activity.

14. The recombinant host cell of claim 13 , wherein the polypeptide having xylanase activity has at least 85% sequence identity to the sequence of amino acids 18 to 364 of SEQ ID NO: 2.

15. The recombinant host cell of claim 13 , wherein the polypeptide having xylanase activity has at least 90% sequence identity to the sequence of amino acids 18 to 364 of SEQ ID NO: 2.

16. The recombinant host cell of claim 13 , wherein the polypeptide having xylanase activity has at least 95% sequence identity to the sequence of amino acids 18 to 364 of SEQ ID NO: 2.

17. The recombinant host cell of claim 13 , wherein the polypeptide having xylanase activity has at least 97% sequence identity to the sequence of amino acids 18 to 364 of SEQ ID NO: 2.

18. The recombinant host cell of claim 13 , wherein the polypeptide having xylanase activity comprises the sequence of SEQ ID NO: 2.

19. The recombinant host cell of claim 13 , wherein the polypeptide having xylanase activity comprises the sequence of amino acids 18 to 364 of SEQ ID NO: 2.

20. The recombinant host cell of claim 13 , wherein the polypeptide having xylanase activity is a fragment of SEQ ID NO: 2, wherein the fragment has xylanase activity.

21. The recombinant host cell of claim 13 , wherein the polypeptide having xylanase activity is encoded by a polynucleotide that hybridizes under very high stringency conditions with the full-length complement of the sequence of nucleotides 52 to 1165 of SEQ ID NO: 1, wherein the very high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 micrograms/ml sheared and denatured salmon sperm DNA, and 50% formamide, and washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 70° C.

22. The recombinant host cell of claim 13 , wherein the polypeptide is a variant of the sequence of amino acids 18 to 364 of SEQ ID NO: 2 comprising a substitution, deletion and/or insertion at one or more positions and wherein the variant has at least 95% sequence identity to the sequence of amino acids 18 to 364 of SEQ ID NO: 2.

23. A method of producing a polypeptide having xylanase activity, comprising:

(a) cultivating the recombinant host cell of claim 13 under conditions conducive for production of the polypeptide; and

(b) recovering the polypeptide.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jul 29, 2019
From: NOVOZYMES, INC.
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 049893/0635 →
Priority Claims (1)
EP 11250700 · Aug 4, 2011 · regional
Continuity (3)
Division 14122431
Provisional Application 61531413 · Sep 6, 2011
Related Publication 20150031079A1 · Jan 29, 2015